Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomimetic Nanoparticles Enabled by Cascade Cell Membrane Coating for Direct Cross‐Priming of T Cells
Fangjie Chen, Zhongmin Geng, Lu Wang, et al.
Small (2021) Vol. 18, Iss. 3
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment
Shu Zhang, Xiaojuan Zhang, Huan Gao, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 531-531
Open Access | Times Cited: 21
Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery
Na-Hyun Lee, Sumin You, Ali Taghizadeh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2223-2223
Open Access | Times Cited: 47
Chiral Ruthenium Nanozymes with Self‐Cascade Reaction Driven the NO Generation Induced Macrophage M1 Polarization Realizing the Lung Cancer “Cocktail Therapy”
Xu Chen, Yonglan Yang, Gang Ye, et al.
Small (2023) Vol. 19, Iss. 28
Closed Access | Times Cited: 33
Advanced subunit vaccine delivery technologies: From vaccine cascade obstacles to design strategies
Yingying Hou, Min Chen, Yuan Bian, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 8, pp. 3321-3338
Open Access | Times Cited: 31
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jingwen Jiang, Yanjuan Huang, Zishan Zeng, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 843-884
Closed Access | Times Cited: 28
Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy
Fei Hou, Zichao Guo, M. Ho, et al.
ACS Nano (2024) Vol. 18, Iss. 12, pp. 8571-8599
Closed Access | Times Cited: 12
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 11
An iron-based metal-organic framework nanoplatform for enhanced ferroptosis and oridonin delivery as a comprehensive antitumor strategy
Mengru Cai, Tingting Fu, Rongyue Zhu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4073-4086
Open Access | Times Cited: 10
Latest Advances in Biomimetic Cell Membrane-Coated and Membrane-Derived Nanovectors for Biomedical Applications
Riccardo Rampado, Paolo Caliceti, Marco Agostini
Nanomaterials (2022) Vol. 12, Iss. 9, pp. 1543-1543
Open Access | Times Cited: 34
Versatile biomimetic nanomedicine for treating cancer and inflammation disease
B. Zhao, Dangge Wang, Yaping Li
Medical Review (2023) Vol. 3, Iss. 2, pp. 123-151
Open Access | Times Cited: 22
Nanovaccines for cancer immunotherapy: Focusing on complex formation between adjuvant and antigen
Nasser Hashemi Goradel, Mahnaz Nemati, Azam Bakhshandeh, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109887-109887
Closed Access | Times Cited: 21
The application of nanoparticles in immunotherapy for hepatocellular carcinoma
Xinyao Hu, Hua Zhu, Xiaoqin He, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 85-108
Closed Access | Times Cited: 20
Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy
Lingyang Meng, Zhuang Teng, Shuang Yang, et al.
Nanoscale (2023) Vol. 15, Iss. 14, pp. 6432-6455
Closed Access | Times Cited: 17
Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects
Jun Chen, Xiufeng Cong
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 113998-113998
Open Access | Times Cited: 24
Construction of Nanocarriers Based on Endogenous Cell Membrane and Their Application in Nanomedicine
Yingshu Guo, Wenxin Li, Shiwei Liu, et al.
Chinese Journal of Chemistry (2022) Vol. 40, Iss. 13, pp. 1623-1640
Closed Access | Times Cited: 23
Nano-drug delivery systems for T cell-based immunotherapy
Rui Li, Zhimin Chen, Juyi Li, et al.
Nano Today (2022) Vol. 46, pp. 101621-101621
Closed Access | Times Cited: 23
Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence
Negin Mozafari, Niloofar Mozafari, Ali Dehshahri, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 8, pp. 3757-3778
Closed Access | Times Cited: 16
STING antagonist-loaded renal tubule epithelial cell-mimicking nanoparticles ameliorate acute kidney injury by orchestrating innate and adaptive immunity
Yuqi Shen, Fengmin Yang, Feng Wu, et al.
Nano Today (2024) Vol. 55, pp. 102209-102209
Closed Access | Times Cited: 6
Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy
Huiyang Liu, Yiming Lu, Jinbao Zong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Recent progress in cancer cell membrane-based nanoparticles for biomedical applications
Qixiong Lin, Yueyou Peng, Yanyan Wen, et al.
Beilstein Journal of Nanotechnology (2023) Vol. 14, pp. 262-279
Open Access | Times Cited: 13
Biomimetic Cell-Derived Nanoparticles: Emerging Platforms for Cancer Immunotherapy
Tingting Hu, Yuezhou Huang, Jing Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1821-1821
Open Access | Times Cited: 11
Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Platform for Tumor Therapy
Chengliang Lyu, Wenjin Wang, Yuan Yang, et al.
JOURNAL OF CHEMICAL ENGINEERING OF JAPAN (2025) Vol. 58, Iss. 1
Open Access
Multifunctional tumor vaccines carrying thalidomide regulate T cell exhaustion and ferroptosis for immunotherapy strategies
Aijin Huang, Ting Li, Ying Zhou, et al.
View (2025)
Open Access
Nanoimmunotherapy: the smart trooper for cancer therapy
Suphiya Parveen, Dhanshree Vikrant Konde, Safal Kumar Paikray, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access
Strategies to Design and Optimize Artificial Antigen‐Presenting Cells for T Cell Expansion in Cancer Immunotherapy
Nguyễn Thị Tuyết, Yu Seok Youn
Advanced Functional Materials (2025)
Open Access
Page 1 - Next Page

Scroll to top